series-a
Stage
2
Investors
About
Thrombolex develops and commercializes endovascular catheters utilizing a hybrid pharmacomechanical approach to treat arterial and venous thromboembolic conditions by restoring blood flow through clot fragmentation and targeted thrombolytic delivery.
Explore Thrombolex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.